MBX Biosciences (MBX) News Today $22.46 -0.44 (-1.92%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period MBX Biosciences (NYSE:MBX) Shares Up 6.8% - Here's What HappenedMBX Biosciences (NYSE:MBX) Stock Price Up 6.8% - Here's What HappenedOctober 29, 2024 | marketbeat.comMBX Biosciences (NYSE:MBX) Sets New 52-Week Low - Time to Sell?MBX Biosciences (NYSE:MBX) Reaches New 1-Year Low - Time to Sell?October 28, 2024 | marketbeat.comMBX Biosciences to Participate in Upcoming November Investor ConferencesOctober 28, 2024 | globenewswire.comMBX Biosciences (NYSE:MBX) Shares Down 4.5% - Here's What HappenedMBX Biosciences (NYSE:MBX) Shares Down 4.5% - Here's What HappenedOctober 25, 2024 | marketbeat.comMBX Biosciences, Inc.'s Quiet Period Set To Expire on October 23rd (NYSE:MBX)MBX Biosciences' (NYSE:MBX - Get Free Report) quiet period will end on Wednesday, October 23rd. MBX Biosciences had issued 10,200,000 shares in its public offering on September 13th. The total size of the offering was $163,200,000 based on an initial share price of $16.00. During MBX Biosciences' quiet period, underwriters and any insiders involved in the IPO are prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.October 16, 2024 | marketbeat.comMBX Biosciences (NYSE:MBX) Stock Price Down 4% - Here's WhyMBX Biosciences (NYSE:MBX) Stock Price Down 4% - Here's What HappenedOctober 14, 2024 | marketbeat.comOpening Day: Another trio of biotech IPOs make Friday debutOctober 14, 2024 | finance.yahoo.comMBX Bio drops despite bullish views on StreetOctober 10, 2024 | msn.comBuy Rating Affirmed on MBX Biosciences, Inc. Based on Promising Therapeutic Pipeline and Market PotentialOctober 10, 2024 | markets.businessinsider.comBuy Rating Affirmed for MBX Biosciences on Strong Clinical Progress and Robust Financial PositionOctober 10, 2024 | markets.businessinsider.comMBX Biosciences (NYSE:MBX) Trading 4.6% Higher - What's Next?MBX Biosciences (NYSE:MBX) Trading Up 4.6% - Still a Buy?October 9, 2024 | marketbeat.comMBX Biosciences (NYSE:MBX) Stock Price Down 3.5% - Should You Sell?MBX Biosciences (NYSE:MBX) Stock Price Down 3.5% - Here's WhyOctober 4, 2024 | marketbeat.comMBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual MeetingSeptember 30, 2024 | globenewswire.comLast Week's 3 Biotech IPOs Prompt Huge Insider BuyingSeptember 22, 2024 | 247wallst.comEdward T. Mathers Acquires 500,000 Shares of MBX Biosciences, Inc. (NYSE:MBX) StockSeptember 18, 2024 | insidertrades.com Get MBX Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here MBX Media Mentions By Week MBX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MBX News Sentiment▼0.150.43▲Average Medical News Sentiment MBX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MBX Articles This Week▼32▲MBX Articles Average Week Get MBX Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Arrowhead Pharmaceuticals News Today Geron News Today ACADIA Pharmaceuticals News Today Longboard Pharmaceuticals News Today Keros Therapeutics News Today Akero Therapeutics News Today Ligand Pharmaceuticals News Today Harmony Biosciences News Today Belite Bio News Today Gemini Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:MBX) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MBX Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MBX Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
